ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 78 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,000 | +1400.0% | 3,236 | +627.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 445 | +46.4% | 0.00% | – |
| Q3 2020 | $1,000 | -99.1% | 304 | -99.2% | 0.00% | – |
| Q1 2020 | $108,000 | -32.1% | 37,509 | -11.1% | 0.00% | – |
| Q4 2019 | $159,000 | +123.9% | 42,188 | +201.5% | 0.00% | – |
| Q3 2019 | $71,000 | +54.3% | 13,991 | +84.7% | 0.00% | – |
| Q2 2019 | $46,000 | -31.3% | 7,574 | -20.4% | 0.00% | – |
| Q1 2019 | $67,000 | +346.7% | 9,517 | +413.9% | 0.00% | – |
| Q4 2018 | $15,000 | -95.9% | 1,852 | -90.0% | 0.00% | -100.0% |
| Q3 2018 | $370,000 | +168.1% | 18,501 | +244.9% | 0.00% | 0.0% |
| Q2 2018 | $138,000 | +40.8% | 5,364 | +29.8% | 0.00% | -75.0% |
| Q1 2018 | $98,000 | -87.1% | 4,134 | -88.5% | 0.00% | -87.1% |
| Q3 2017 | $762,000 | +76.4% | 36,024 | +135.7% | 0.03% | -8.8% |
| Q4 2015 | $432,000 | – | 15,281 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |